This letter – co-signed by the HIV Legal Network and other organizations that work directly with or advocate for the rights-respecting treatment of people in federal custody – shares serious concerns about the impacts of the October 1, 2025 changes to Correctional Services Canada’s Opioid Agonist Treatment policy, including the delisting of Suboxone and the addition of Sublocade as the first line treatment for Opioid Use Disorder (OUD) in the National Formulary, based on direct reports from people who are incarcerated in federal institutions across Canada.
Letter to CSC Health Services OAT Policy Changes – October 1, 2025
Author
Topics
Access to Medicines, Drug Policy, Prisons
Language
English